data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Atea Pharmaceuticals
(NASDAQ:AVIR)
$7.31
0.25[3.54%]
At close: Jun 29
$7.31
00
After Hours: 4:08PM EDT
15 minutes delayed
Day High/Low6.92 - 7.34
52 Week High/Low5.31 - 46.91
Open / Close7.01 / 7.31
Float / Outstanding63.2M / 83.3M
Vol / Avg.504.9K / 739K
Mkt Cap608.6M
P/E13.58
50d Avg. Price6.84
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float63.2M

Atea Pharmaceuticals (NASDAQ:AVIR), Quotes and News Summary

Atea Pharmaceuticals (NASDAQ: AVIR)

Day High/Low6.92 - 7.34
52 Week High/Low5.31 - 46.91
Open / Close7.01 / 7.31
Float / Outstanding63.2M / 83.3M
Vol / Avg.504.9K / 739K
Mkt Cap608.6M
P/E13.58
50d Avg. Price6.84
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float63.2M
Benzinga - Sponsored
Benzinga - May 18, 2022, 12:26PM
Benzinga - May 10, 2022, 6:56AM
Benzinga - Mar 2, 2022, 10:11AM
Benzinga - Mar 1, 2022, 9:09AM
Benzinga - Mar 1, 2022, 5:04AM
Benzinga - Feb 28, 2022, 4:50PM
Benzinga - Feb 16, 2022, 5:18AM
Benzinga - Feb 2, 2022, 7:15AM
Benzinga - Jan 7, 2022, 7:04AM
Benzinga - Jan 6, 2022, 9:50AM
Benzinga - Jan 6, 2022, 8:18AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The company's medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.580-0.510 0.0700
REV3.330M0-3.330M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Atea Pharmaceuticals Questions & Answers

Q
How do I buy Atea Pharmaceuticals (AVIR) stock?
A

You can purchase shares of Atea Pharmaceuticals (NASDAQ: AVIR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Atea Pharmaceuticals's (AVIR) competitors?
Q
What is the target price for Atea Pharmaceuticals (AVIR) stock?
A

The latest price target for Atea Pharmaceuticals (NASDAQ: AVIR) was reported by JP Morgan on Wednesday, March 2, 2022. The analyst firm set a price target for 8.00 expecting AVIR to rise to within 12 months (a possible 9.44% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Atea Pharmaceuticals (AVIR)?
A

The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $7.31 last updated Today at June 29, 2022, 8:00 PM UTC.

Q
Does Atea Pharmaceuticals (AVIR) pay a dividend?
A

There are no upcoming dividends for Atea Pharmaceuticals.

Q
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
A

Atea Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Atea Pharmaceuticals (AVIR) going to split?
A

There is no upcoming split for Atea Pharmaceuticals.

Q
What sector and industry does Atea Pharmaceuticals (AVIR) operate in?
A

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.